Stifel analyst Justin Keywood maintained his “Buy” rating and $9.00 target price on WELL Health Technologies (WELL Health Technologies Stock Quote, Chart, News, Analysts, Financials TSX:WELL) in an Aug. 21 report, pointing to catalysts from divestitures, M&A, and the company’s fast-growing software platform. “WELL has an ecosystem of over 80 healthcare assets, where there exists substantial value to […]
Haywood Capital Markets analyst Neal Gilmer raised his target price on Rubicon Organics (Rubicon Organics Stock Quote, Chart, News, Analysts, Financials TSXV:ROMJ) to $1.30 from $1.10 in an Aug. 18 report, citing stronger-than-expected second quarter results. “The company expects to receive licensing approval from Health Canada for the Hope facility by year-end, after which management […]
Share
Tweet
Share
